Teladoc Health Inc (NYSE:TDOC) President Peter A. Mcclennen Sells 13,753 Shares

Teladoc Health Inc (NYSE:TDOC) President Peter A. Mcclennen sold 13,753 shares of the firm’s stock in a transaction on Monday, July 15th. The stock was sold at an average price of $70.99, for a total value of $976,325.47. Following the transaction, the president now owns 29,412 shares of the company’s stock, valued at $2,087,957.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Peter A. Mcclennen also recently made the following trade(s):

  • On Wednesday, July 10th, Peter A. Mcclennen sold 9,670 shares of Teladoc Health stock. The stock was sold at an average price of $70.00, for a total value of $676,900.00.

NYSE:TDOC traded up $0.53 during midday trading on Friday, reaching $69.06. The company had a trading volume of 28,766 shares, compared to its average volume of 966,275. The firm has a market cap of $4.91 billion, a price-to-earnings ratio of -47.96 and a beta of 1.30. The business’s fifty day simple moving average is $62.99. Teladoc Health Inc has a 12-month low of $42.08 and a 12-month high of $89.05. The company has a debt-to-equity ratio of 0.42, a current ratio of 7.54 and a quick ratio of 7.54.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, April 30th. The health services provider reported ($0.43) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.44) by $0.01. The firm had revenue of $128.57 million during the quarter, compared to analyst estimates of $127.99 million. Teladoc Health had a negative return on equity of 10.86% and a negative net margin of 22.63%. Teladoc Health’s revenue was up 43.4% compared to the same quarter last year. During the same period last year, the business posted ($0.39) earnings per share. As a group, equities research analysts predict that Teladoc Health Inc will post -1.53 earnings per share for the current fiscal year.

Institutional investors have recently bought and sold shares of the business. CENTRAL TRUST Co raised its stake in Teladoc Health by 82.6% in the second quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock valued at $27,000 after buying an additional 171 shares in the last quarter. Meridian Wealth Management LLC acquired a new stake in Teladoc Health in the second quarter valued at $27,000. Tompkins Financial Corp acquired a new stake in Teladoc Health in the first quarter valued at $31,000. Cornerstone Advisors Inc. raised its stake in Teladoc Health by 187.0% in the second quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock valued at $31,000 after buying an additional 303 shares in the last quarter. Finally, Flagship Harbor Advisors LLC raised its stake in Teladoc Health by 87.8% in the first quarter. Flagship Harbor Advisors LLC now owns 616 shares of the health services provider’s stock valued at $34,000 after buying an additional 288 shares in the last quarter.

Several research analysts have recently commented on the company. Stephens restated a “neutral” rating on shares of First Horizon National in a research report on Tuesday, April 16th. Cantor Fitzgerald restated a “buy” rating and set a $143.00 price target on shares of Eli Lilly And Co in a research report on Tuesday, April 30th. Zacks Investment Research lowered Inflarx from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Craig Hallum raised their price target on 1-800-Flowers.Com from $26.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Finally, Guggenheim started coverage on Patterson Companies in a research report on Wednesday, April 17th. They set a “neutral” rating and a $23.00 price target for the company. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $82.68.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Market Capitalization in the Stock Market

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.